New Antibodies Aimed at Drugs of Abuse Targets

By LabMedica International staff writers
Posted on 12 Jul 2011

A recently released range of drug-targeted antibodies including anti-haloperidol, anti-methicathinone, anti-norfentanyl, and anti-theophylline has been added to an already impressive catalog of drug-targeted antibodies for research and development applications.

Randox Life Sciences (Crumlin, United Kingdom) has been involved in the development and manufacture of life sciences research products for more than 30 years. Their products include recombinant proteins, polyclonal antibodies, and conjugates targeting drugs of abuse, steroids, hormones, and biochemical markers. These products are manufactured at their ISO 13485 certified manufacturing plant in the United Kingdom.

In the field of drugs of abuse testing, Randox has assembled a large catalog of antibodies and conjugates specific for antidepressants, barbiturates, benzodiazepines, hallucinogens, opiates, sedatives, stimulants, and therapeutic drugs.

Related Links:
Randox Life Sciences